НАИМА-ФАРМ, ООО

Wholesale of pharmaceutical goods

BIN 00309202010119 · Reg. no. 192317-3303-ООО
Download free PDF

No sign-up or report credits required

Contacts8

Phone

+996 (░░░) ░░-░░░░

Email

░░░@░░░.░░

Website

░░░.░░░.░░░

Social networks

Get a detailed company report

Management and founders
Contact information
Risk factors
Registry checks
Court cases
History of changes to management, names, and addresses
Affiliated individuals and companies
By clicking the button, you agree to the terms of use and privacy policy.

Data updated: 12.06.2026

Business activity

Equity holdings in other companies

Connections and affiliations

  • 43 total connections
  • 6 by founders
  • 12 by address
  • 12 by management
  • 8 by contact

Court cases

Organizational structure

Address

Country

Kyrgyzstan

Region

Jalal-abad Region

House number and street

Jalal-Abad Region, Nookenskii Raion, Ul.Gagarina, 5, Kv.2

Unit

Kv.2

Locality

Jalal-abad Region

About ООО «НАИМА-ФАРМ»

НАИМА-ФАРМ, ООО was registered on 03.09.2020.

Limited liability company «НАИМА-ФАРМ»: registration details and status

The company has the status “Active”. Registered address — Jalal-Abad Region, Nookenskii Raion, Ul.Gagarina, 5, Kv.2, region — Jalal-abad Region, Kyrgyz Republic. Primary activity — Wholesale of pharmaceutical goods (OKED 46.46.0). Business category — Small enterprise, ownership type — Private.

Management of ООО «НАИМА-ФАРМ»

Officers of ООО «НАИМА-ФАРМ»: Hamitov Medetbek Taalaibekovich, Hamitov Medetbek Taalajbekovich.

Verification of ООО «НАИМА-ФАРМ» in official registries of the Kyrgyz Republic

Phone numbers, e-mail addresses, websites (8 contacts), and the list of officers of ООО «НАИМА-ФАРМ» are available in the full Statsnet report. All the data to verify ООО «НАИМА-ФАРМ» as a counterparty: financial indicators, government contracts, court cases, affiliations, and risks — based on official registry data of the Kyrgyz Republic in the Statsnet report. You can find any company by BIN or name via Statsnet search.

Frequently asked questions